
The Silent Threat of Frailty and Sarcopenia
Frailty and sarcopenia (FSSG) are critical health conditions associated with increased risk of falls, disability, and mortality. Early identification is essential for preventing adverse outcomes. However, traditional assessments of frailty and sarcopenia often lack precision and timeliness, hindering effective patient management.

The Devastating Impact of Frailty and Sarcopenia
Frailty and sarcopenia significantly impact patients’ quality of life, leading to reduced independence, increased healthcare utilization, and higher mortality rates. These conditions pose a substantial burden on both patients and healthcare systems.

Kribado: Your Partner in Frailty and Sarcopenia Management
Transform Patient Care with Instant FSSG Assessment
Kribado is an innovative patient screening solution designed to accurately and efficiently assess frailty and sarcopenia risk. By leveraging the FSSG and advanced algorithms, Kribado empowers healthcare providers to optimize treatment plans and improve patient outcomes.
How Kribado Works
- Rapid FSSG Assessment: Quickly assess patient frailty and sarcopenia risk.
- Data-Driven Insights: Gain valuable information to tailor treatment plans.
- Improved Patient Outcomes: Enhance patient independence and quality of life.
- Efficient Workflow Integration: Seamlessly integrate FSSG assessments into clinical practice.

Trusted by Pharmaceutical Leaders
Indigital Technologies LLP is a proven leader in pharmaceutical business growth. With a strong track record of delivering innovative solutions, we are committed to improving patient care and driving industry progress.
- Highlight key achievements: Mention number of pharmaceutical brands worked with, revenue generated, patents, and customer satisfaction ratings.
- Showcase expertise: Emphasize experience in working with various therapeutic areas and developing risk scores.